Convincing or confusing?: Economic evaluations of childhood pneumococcal conjugate vaccination—a review (2002–2006)
- 9 February 2007
- Vol. 25 (8) , 1355-1367
- https://doi.org/10.1016/j.vaccine.2006.10.034
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Pneumococcal pneumonia in the UK—how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)Vaccine, 2005
- Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccinationVaccine, 2004
- The cost-effectiveness of pneumococcal conjugate vaccination in AustraliaVaccine, 2004
- A Pharmacoeconomic Evaluation of Seven-Valent Pneumococcal Conjugate Vaccine in SpainValue in Health, 2004
- Economic Aspects of Pneumococcal PneumoniaPharmacoEconomics, 2004
- Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the NetherlandsClinical Therapeutics, 2003
- The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccineVaccine, 2003
- Benefits and costs of immunization of children with pneumococcal conjugate vaccine in CanadaVaccine, 2003
- A Pharmacoeconomic Evaluation of 7‐Valent Pneumococcal Conjugate Vaccine in CanadaClinical Infectious Diseases, 2003
- Cost Effectiveness of Pneumococcal Vaccination for Infants and Children with the Conjugate Vaccine PnC-7 in GermanyPharmacoEconomics, 2003